Genome-Wide Profiling of Pluripotent Cells Reveals a Unique Molecular Signature of Human Embryonic Germ Cells

Human embryonic germ cells (EGCs) provide a powerful model for identifying molecules involved in the pluripotent state when compared to their progenitors, primordial germ cells (PGCs), and other pluripotent stem cells. Microarray and Principal Component Analysis (PCA) reveals for the first time that human EGCs possess a transcription profile distinct from PGCs and other pluripotent stem cells. Validation with qRT-PCR confirms that human EGCs and PGCs express many pluripotency-associated genes but with quantifiable differences compared to pluripotent embryonic stem cells (ESCs), induced pluripotent stem cells (IPSCs), and embryonal carcinoma cells (ECCs). Analyses also identified a number of target genes that may be potentially associated with their unique pluripotent states. These include IPO7, MED7, RBM26, HSPD1, and KRAS which were upregulated in EGCs along with other pluripotent stem cells when compared to PGCs. Other potential target genes were also found which may contribute toward a primed ESC-like state. These genes were exclusively up-regulated in ESCs, IPSCs and ECCs including PARP1, CCNE1, CDK6, AURKA, MAD2L1, CCNG1, and CCNB1 which are involved in cell cycle regulation, cellular metabolism and DNA repair and replication. Gene classification analysis also confirmed that the distinguishing feature of EGCs compared to ESCs, ECCs, and IPSCs lies primarily in their genetic contribution to cellular metabolism, cell cycle, and cell adhesion. In contrast, several genes were found upregulated in PGCs which may help distinguish their unipotent state including HBA1, DMRT1, SPANXA1, and EHD2. Together, these findings provide the first glimpse into a unique genomic signature of human germ cells and pluripotent stem cells and provide genes potentially involved in defining different states of germ-line pluripotency

Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors

10.1371/journal.pone.0116933PLoS ONE101e011693

Neuroprotective Role of Hypothermia in Acute Spinal Cord Injury

Even nowadays, the question of whether hypothermia can genuinely be considered therapeutic care for patients with traumatic spinal cord injury (SCI) remains unanswered. Although the mechanisms of hypothermia action are yet to be fully explored, early hypothermia for patients suffering from acute SCI has already been implemented in clinical settings. This article discusses measures for inducing various forms of hypothermia and summarizes several hypotheses describing the likelihood of hypothermia mechanisms of action. We present our objective neuro-electrophysiological results and demonstrate that early hypothermia manifests neuroprotective effects mainly during the first- and second-month post-SCI, depending on the severity of the injury, time of intervening, duration, degree, and modality of inducing hypothermia. Nevertheless, eventually, its beneficial effects gradually but consistently diminish. In addition, we report potential complications and side effects for the administration of general hypothermia with a unique referment to the local hypothermia. We also provide evidence that instead of considering early hypothermia post-SCI a therapeutic approach, it is more a neuroprotective strategy in acute and sub-acute phases of SCI that mostly delay, but not entirely avoid, the natural history of the pathophysiological events. Indeed, the most crucial rationale for inducing early hypothermia is to halt these devastating inflammatory and apoptotic events as early and as much as possible. This, in turn, creates a larger time-window of opportunity for physicians to formulate and administer a well-designed personalized treatment for patients suffering from acute traumatic SCI

Novel modeling of somatosensory evoked potentials for the assessment of spinal cord injury

Abstract Objective: Previous work has shown that differences in the somatosensory evoked potential (SEP) signals between a normal spinal pathway and spinal pathway affected by spinal cord injury (SCI) provide a means to study the degree of injury. This paper proposes a novel quantitative SCI assessment method using time-domain SEP signals. Methods: A pruned and unstructured fit between SEP signals from a normal spinal pathway and a spinal pathway affected by SCI is developed using methods inspired by recent results in sparse reconstruction theory. The coefficients from the resulting fit are used to develop a quantitative assessment of SCI that is tested on actual SEP signals collected from rodents that have been subjected to partial and complete spinal cord transection. Results: The proposed method provides a rich parametric measure that integrates SEP amplitude, time latency, and morphology, while exhibiting a high degree of correlation with existing subjective and quantitative SCI assessment methods. Conclusion: The proposed SCI encapsulates a model of the injury to quantify SCI. Significance: The proposed SCI quantification method may be used to complement existing SCI assessment methods

Assessment of spinal cord injury via sparse modeling of somatosensory evoked potential signals

Abstract The morphological differences between somatosensory evoked potential (SEP) signals from a normal spinal pathway and spinal pathway affected by spinal cord injury (SCI) provide an indication of the degree of SCI. A sparse representation of the fit between these signals is proposed in this paper as an SCI assessment method. The proposed method is tested on actual SEP signals collected from rodents that have been subjected to spinal transection. Results indicate that the proposed method provides a robust measure of the different degrees of SCI resulting from transection of the spinal cord

Effect of isoflurane on somatosensory evoked potentials in a rat model

10.1109/EMBC.2014.69445722014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 20144286-428